Published in Pathobiology on January 01, 2007
Quality management and accreditation of research tissue banks: experience of the National Center for Tumor Diseases (NCT) Heidelberg. Virchows Arch (2010) 1.55
The role of the pathologist in tissue banking: European Consensus Expert Group Report. Virchows Arch (2010) 1.44
Institutional shared resources and translational cancer research. J Transl Med (2009) 1.41
The evolution of biobanking best practices. Clin Chim Acta (2012) 1.34
Evolutionary concepts in biobanking - the BC BioLibrary. J Transl Med (2009) 1.29
The Spanish HIV BioBank: a model of cooperative HIV research. Retrovirology (2009) 1.26
Biobanking past, present and future: responsibilities and benefits. AIDS (2013) 1.17
An Australian Brain Bank: a critical investment with a high return! Cell Tissue Bank (2008) 1.13
The Infectious Diseases BioBank at King's College London: archiving samples from patients infected with HIV to facilitate translational research. Retrovirology (2009) 1.05
The HOPE fixation technique--a promising alternative to common prostate cancer biobanking approaches. BMC Cancer (2011) 0.97
Quantifying histological features of cancer biospecimens for biobanking quality assurance using automated morphometric pattern recognition image analysis algorithms. J Biomol Tech (2011) 0.92
Digital pathology and image analysis augment biospecimen annotation and biobank quality assurance harmonization. Clin Biochem (2013) 0.83
Structural requirements of research tissue banks derived from standardized project surveillance. Virchows Arch (2012) 0.81
A biorepository for ophthalmic surgical specimens. Proteomics Clin Appl (2013) 0.80
Frameworks for Proof-of-Concept Clinical Trials of Interventions That Target Fundamental Aging Processes. J Gerontol A Biol Sci Med Sci (2016) 0.78
Gene mutations responsible for primary immunodeficiency disorders: A report from the first primary immunodeficiency biobank in Iran. Allergy Asthma Clin Immunol (2016) 0.75
[Maintainance of a research tissue bank : (Infra)structural and quality aspects]. Pathologe (2015) 0.75
Multicenter fresh frozen tissue sampling in colorectal cancer: does the quality meet the standards for state of the art biomarker research? Cell Tissue Bank (2017) 0.75
A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma. Eur J Cancer (2001) 1.91
Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy. Eur J Cancer (2003) 1.70
High-throughput microRNAome analysis in human germ cell tumours. J Pathol (2007) 1.60
IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide. Neurology (2009) 1.57
Malignant struma ovarii treated by ovariectomy, thyroidectomy, and 131I administration. Cancer (1987) 1.50
Absence of c-KIT and members of the epidermal growth factor receptor family in refractory germ cell cancer. Cancer (2002) 1.46
Gonadal and extragonadal germ cell tumours in the United States, 1973-2007. Int J Androl (2012) 1.46
Pathogenesis of testicular germ cell tumours. Rev Reprod (1999) 1.46
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol (2012) 1.44
Combination therapy with cisplatin: modulation of activity and tumour sensitivity. Clin Oncol (R Coll Radiol) (1992) 1.43
Successful surgical treatment of parathyroid carcinoma in two haemodialysis patients. Nephrol Dial Transplant (1990) 1.43
Endodermal sinus tumor of the ovary during pregnancy: a case report. Am J Obstet Gynecol (1991) 1.40
Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications. J Pathol (2008) 1.33
Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2-p12.1. Oncogene (2003) 1.32
FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD). J Pathol (2008) 1.29
Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis. Int J Androl (2011) 1.26
Cytogenetic analysis of epithelial renal-cell tumors: relationship with a new histopathological classification. Int J Cancer (1993) 1.25
Cervical tissue shrinkage by formaldehyde fixation, paraffin wax embedding, section cutting and mounting. Virchows Arch A Pathol Anat Histopathol (1983) 1.23
TuBaFrost 2: Standardising tissue collection and quality control procedures for a European virtual frozen tissue bank network. Eur J Cancer (2006) 1.20
Tumor risk in disorders of sex development. Sex Dev (2010) 1.17
Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors. J Natl Cancer Inst (1994) 1.17
Differentiation of TERA-2 human embryonal carcinoma cells into neurons and HCMV permissive cells. Induction by agents other than retinoic acid. Differentiation (1986) 1.14
Mesenchymal and muscle-specific intermediate filaments (vimentin and desmin) in relation to differentiation in childhood rhabdomyosarcomas. Hum Pathol (1985) 1.08
Localization and polymorphism of a chromosome 12-specific alpha satellite DNA sequence. Cytogenet Cell Genet (1990) 1.08
Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (2000) 1.08
Cytologic "differentiation" in childhood rhabdomyosarcomas following polychemotherapy. Hum Pathol (1984) 1.07
Loss of heterozygosity at the short arm of chromosome 3 in renal-cell cancer correlates with the cytological tumour type. Int J Cancer (1993) 1.06
Allelotype of 28 human breast cancer cell lines and xenografts. Br J Cancer (2003) 1.06
Comparative genomic hybridization of germ cell tumors of the adult testis: confirmation of karyotypic findings and identification of a 12p-amplicon. Cancer Genet Cytogenet (1996) 1.05
Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours. Int J Cancer (1996) 1.05
Carcinoma in situ in the testis. Scand J Urol Nephrol Suppl (2000) 1.05
Unique expression patterns of H19 in human testicular cancers of different etiology. Oncogene (1997) 1.03
Gonadal pathology and tumor risk in relation to clinical characteristics in patients with 45,X/46,XY mosaicism. J Clin Endocrinol Metab (2011) 1.03
X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status. Am J Pathol (1997) 1.03
Pathogenesis of adult testicular germ cell tumors. A cytogenetic model. Cancer Genet Cytogenet (1990) 1.03
Evaluation of testicular biopsies for carcinoma in situ: immunohistochemistry is mandatory. Int J Androl (2008) 1.02
TuBaFrost 3: regulatory and ethical issues on the exchange of residual tissue for research across Europe. Eur J Cancer (2006) 1.01
Stem cell factor as a novel diagnostic marker for early malignant germ cells. J Pathol (2008) 1.00
Combined optical coherence tomography and intravascular ultrasound radio frequency data analysis for plaque characterization. Classification accuracy of human coronary plaques in vitro. Int J Cardiovasc Imaging (2010) 1.00
Bilateral testicular microlithiasis predicts the presence of the precursor of testicular germ cell tumors in subfertile men. J Urol (2004) 0.99
The region of common allelic losses in sporadic renal cell carcinoma is bordered by the loci D3S2 and THRB. Genomics (1991) 0.96
Chromosomal constitution of human spermatocytic seminomas: comparative genomic hybridization supported by conventional and interphase cytogenetics. Genes Chromosomes Cancer (1998) 0.95
Chromosomal changes in renal oncocytomas. Evidence that t(5;11)(q35;q13) may characterize a second subgroup of oncocytomas. Cancer Genet Cytogenet (1995) 0.95
cis-diamminedichloroplatinum(ii) resistance in vitro and in vivo in human embryonal carcinoma cells. Cancer Res (1993) 0.95
Cervical lymph node dissection for metastatic testicular cancer. Ann Surg Oncol (2010) 0.95
Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience. Ann N Y Acad Sci (2006) 0.95
N- and KRAS mutations in primary testicular germ cell tumors: incidence and possible biological implications. Genes Chromosomes Cancer (1995) 0.94
Heterogeneous X inactivation in trophoblastic cells of human full-term female placentas. Am J Hum Genet (1999) 0.94
Pitfalls in molecular analysis for mismatch repair deficiency in a family with biallelic pms2 germline mutations. Clin Genet (2011) 0.93
No recurrent structural abnormalities apart from i(12p) in primary germ cell tumors of the adult testis. Genes Chromosomes Cancer (1995) 0.93
Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsy. Ann Oncol (2003) 0.93
Overrepresentation of the short arm of chromosome 12 is related to invasive growth of human testicular seminomas and nonseminomas. Oncogene (2000) 0.93
Aberrant platelet-derived growth factor alpha-receptor transcript as a diagnostic marker for early human germ cell tumors of the adult testis. Proc Natl Acad Sci U S A (1996) 0.93
Relevance of microRNAs in normal and malignant development, including human testicular germ cell tumours. Int J Androl (2007) 0.93
Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeats. Br J Cancer (2010) 0.92
Cytogenetic analysis of ten human seminomas. Cancer Res (1989) 0.92
Microsatellite instability in a pleomorphic rhabdomyosarcoma in a patient with hereditary non-polyposis colorectal cancer. Histopathology (2003) 0.92
TuBaFrost 1: Uniting local frozen tumour banks into a European network: an overview. Eur J Cancer (2006) 0.91
A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting. Gut (2008) 0.91
Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast cultures. FEBS Lett (1998) 0.91
Direct molecular analysis of a deletion of 3p in tumors from patients with sporadic renal cell carcinoma. Cancer Genet Cytogenet (1988) 0.91
Megaprostheses in the treatment of primary malignant and metastatic tumors in the hip region. J Surg Oncol (1989) 0.90
Sarcoid reaction mimicking intrathoracic dissemination of testicular cancer. Cancer (1990) 0.89
Analysis of cryolesions in the uterine cervix: application techniques, extension, and failures. Obstet Gynecol (1990) 0.89
Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance. Int J Androl (2011) 0.89
High-resolution array comparative genomic hybridization of chromosome 8q: evaluation of putative progression markers for gastroesophageal junction adenocarcinomas. Cytogenet Genome Res (2007) 0.89
Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis. Am J Pathol (2000) 0.88
Comparative genomic hybridization in hypotriploid/hyperdiploid tumors. Cytometry (1997) 0.88
Origin and biology of a testicular Wilms' tumor. Genes Chromosomes Cancer (1994) 0.88
Identification of the critical region of 12p over-representation in testicular germ cell tumors of adolescents and adults. Oncogene (1998) 0.88
Treatment of malignant fibrous histiocytoma of bone. A plea for primary chemotherapy. Cancer (1985) 0.88
Cytogenetics of a renal adenocarcinoma in a 2-year-old child. Cancer Genet Cytogenet (1986) 0.88
Gonadal development and tumor formation at the crossroads of male and female sex determination. Sex Dev (2011) 0.87
Complete association of loss of heterozygosity of chromosomes 13 and 17 in osteosarcoma. Cancer Genet Cytogenet (1991) 0.87
Overrepresentation of chromosome 12p sequences and karyotypic evolution in i(12p)-negative testicular germ-cell tumors revealed by fluorescence in situ hybridization. Cancer Genet Cytogenet (1993) 0.87
In situ numeric analysis of centromeric regions of chromosomes 1, 12, and 15 of seminomas, nonseminomatous germ cell tumors, and carcinoma in situ of human testis. Lab Invest (1993) 0.87
Demonstration of the genuine iso-12p character of the standard marker chromosome of testicular germ cell tumors and identification of further chromosome 12 aberrations by competitive in situ hybridization. Am J Hum Genet (1991) 0.87
The viability of cells in the waste products of CO2-laser evaporation of Cloudman mouse melanomas. Cancer (1982) 0.87
Carcinoid in a horseshoe kidney. Morphology, immunohistochemistry, and cytogenetics. Cancer Genet Cytogenet (1995) 0.87
Chromosomal changes in human primary testicular nonseminomatous germ cell tumors. Cancer Res (1989) 0.87
Biopsy of bone tumours. J Surg Oncol (1985) 0.87
Apoptosis of human seminoma cells upon disruption of their microenvironment. Br J Cancer (1996) 0.86
Raman spectroscopic analysis identifies testicular microlithiasis as intratubular hydroxyapatite. J Urol (2004) 0.86
Sublocalization of c-myb to 6q21----q23 by in situ hybridization and c-myb expression in a human teratocarcinoma with 6q rearrangements. Cytogenet Cell Genet (1986) 0.86
A molecular model for the development of germ cell cancer. Int J Cancer (1999) 0.86
Cytogenetics of carcinoma in situ of the testis. Cancer Genet Cytogenet (1990) 0.86
Experimental testicular germ cell tumorigenesis in mouse strains with and without spontaneous tumours differs from development of germ cell tumours of the adult human testis. Int J Androl (1993) 0.86
Alpha satellite DNAs on chromosomes 10 and 12 are both members of the dimeric suprachromosomal subfamily, but display little identity at the nucleotide sequence level. Genomics (1992) 0.86
Femoropopliteal arterial fibrodysplasia. Br J Surg (1990) 0.85
Molecular characterization of a recurring complex chromosomal translocation in two human extragonadal germ cell tumors. Cancer Genet Cytogenet (1994) 0.85
Genomic copy number and expression patterns in testicular germ cell tumours. Br J Cancer (2007) 0.85
Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model. Br J Cancer (2000) 0.85
Enhancement of cisplatin and etoposide cytotoxicity after all-trans retinoic-acid-induced cellular differentiation of a murine embryonal carcinoma cell line. Int J Cancer (1993) 0.85
TuBaFrost 5: multifunctional central database application for a European tumor bank. Eur J Cancer (2006) 0.85